Jane Street’s Context Therapeutics CNTX Stock Holding History

Jane Street’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Buy	645,209 +208,278	+48%	+$422K	﹤0.01%	8818
2026 Q1	$1.14M	Buy	+436,931	New	+$1.02M	﹤0.01%	6220
2025 Q1	–	Sell	-27,395	Closed	-$28.8K	–	9561
2024 Q4	$28.8K	Buy	+27,395	New	+$47.4K	﹤0.01%	9087
2023 Q1	–	Sell	-19,827	Closed	-$12.9K	–	9134
2022 Q4	$12.9K	Sell	19,827 -52,233	-72%	-$56.3K	﹤0.01%	8704
2022 Q3	$80K	Buy	+72,060	New	+$130K	﹤0.01%	8751

Other funds holding CNTX

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Jane Street's CNTX Position: Q2 2026 in Review

Jane Street increased its Context Therapeutics (CNTX) stake by 48% in Q2 2026, buying an estimated $422K and bringing the position to 645,209 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #8818.

Jane Street first reported a position in CNTX in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.14M in Q1 2026. 79 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

Jane Street held 645,209 shares of Context Therapeutics worth $357K as of Q2 2026.
Jane Street bought 208,278 Context Therapeutics shares in Q2 2026, an estimated $422K.
Context Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8818 holding.
Jane Street first reported a position in Context Therapeutics in Q3 2022 and has held it in 5 quarters since.
Jane Street's Context Therapeutics position peaked at $1.14M in Q1 2026.
79 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.